GigaGen Publishes Research on Company’s Recombinant Hyperimmunes in Nature Biotechnology

NEXT STORY
Healixa Inc. to Establish Nationally Recognized Medical Advisory Committee
PREV STORY
GBS, Inc. Receives Approval to Commence Validation Clinical Study for Rapid SARS-CoV-2 Diagnostic Test
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

RGF® Environmental Group HALO-LED™ Proven to Reduce Coronavirus Surrogate MS2 Bacteriophage by 99% in Independent Testing

author_avatar
NASDAQ Market News

Fennec Pharmaceuticals Receives Complete Response Letter from the FDA for its New Drug Application for PEDMARK™ to Prevent Ototoxicity Associated with Cisplatin in Pediatric Patients with Localized, Non-Metastatic, Solid Tumors

author_avatar
NASDAQ Market News

Santhera Announces Completion of First 6-Month Period of Pivotal VISION-DMD Trial with Vamorolone in Duchenne Muscular Dystrophy

author_avatar
NASDAQ Market News